Stage IIIB Breast Cancer Terminated Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs